Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Enlivex ( (ENLV) ) has issued an announcement.
On February 3, 2026, Enlivex Therapeutics Ltd. held an Extraordinary General Meeting of Shareholders at which investors approved, by the required majorities, all proposals presented, including a series of amendments to the company’s Articles of Association. The updated charter, which formalizes the company’s corporate governance, share capital framework and internal control structure across areas such as general meetings, the board, committees, indemnification, auditing and dividend policy, has been filed with the U.S. Securities and Exchange Commission and incorporated into Enlivex’s existing shelf and equity compensation registration statements, underscoring a tightening of its legal and governance infrastructure that is relevant for current and prospective shareholders.
The most recent analyst rating on (ENLV) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Enlivex stock, see the ENLV Stock Forecast page.
Spark’s Take on ENLV Stock
According to Spark, TipRanks’ AI Analyst, ENLV is a Neutral.
The score is held down mainly by weak financial performance (no revenue, ongoing losses, and persistent cash burn despite improvement) and a valuation profile dominated by negative earnings. Technicals provide partial support due to a clear uptrend, but overbought momentum readings add near-term risk.
To see Spark’s full report on ENLV stock, click here.
More about Enlivex
Enlivex Therapeutics Ltd. is an Israel-based biotechnology company, incorporated under Israeli law, that operates as a company limited by shares and is authorized to engage in any lawful business. Its capital structure consists solely of ordinary shares with equal voting, dividend and liquidation rights, and its ordinary shares are listed in the United States as a foreign private issuer under the Securities Exchange Act of 1934.
Average Trading Volume: 4,076,066
Technical Sentiment Signal: Hold
Current Market Cap: $261.1M
Find detailed analytics on ENLV stock on TipRanks’ Stock Analysis page.